TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

88.40$ -0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow WGS
Line item 2019 2020 2021 2022 2023 2024 2025
-9.5% -51.9% -89.7% -136.0% -88.9% -9.3% 7.8%
3.3% 6.5% 10.3% 25.3% 17.7% 7.2% 5.9%
2.8% 67.0% 103.4% 17.9% -0.2% 3.0% 7.5%
2.7% 68.4% 11.8% 57.0% – – –
-0.4% 7.7% 3.8% 15.4% -18.9% -8.1% -3.6%
7.9% 17.8% 9.8% 6.1% 2.8% 1.8% 4.4%
-7.9% -17.8% -9.8% -60.2% -21.6% -9.9% -14.4%
– – – 85.5% – – –
-0.9% 6.5% -6.3% -1.4% 21.2% -1.1% -0.9%
75.4% 72.0% 232.7% 84.1% 91.9% 14.5% 11.2%
58.0% 2.2% 133.1% -112.1% -18.6% -4.7% 4.6%
-17.4% -69.8% -99.5% -142.1% -91.8% -11.1% 3.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?